HRT FINANCIAL LP

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1475597 NEW YORK, NY

Position in ADPT

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,821,625

-$195,870 QoQ

Shares Held

131,241

+5.6% QoQ

Ownership

0.082%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $56,167,229 across 14 Diagnostics & Research names. ADPT ranks #6 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DHR	Danaher Corp /De/	177,683	$33,688,696
2	MYGN	Myriad Genetics Inc	1,786,319	$8,038,435
3	MEDP	Medpace Holdings, Inc.	7,571	$3,635,518
4	QGEN	Qiagen N.V.	72,302	$2,894,972
5	SHC	Sotera Health Co	139,192	$1,996,013
6	ADPT	Adaptive Biotechnologies Corp This page	131,241	$1,821,625
7	PSNL	Personalis, Inc.	208,891	$1,330,635
8	VCYT	Veracyte, Inc.	31,312	$1,008,559

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,821,625	131,241	+5.6%	Shares	Defined	2026-05-14
2025-12-31	$2,017,495	124,230	+26.3%	Shares	Defined	2026-02-12
2024-12-31	$589,650	98,357	+118.7%	Shares	Defined	2025-02-14
2024-09-30	$230,241	44,969	+178.5%	Shares	Defined	2024-11-12
2023-06-30	$108,332	16,145	-84.8%	Shares	Defined	2023-08-11
2023-03-31	$935,344	105,928	-16.8%	Shares	Defined	2023-05-12
2022-12-31	$972,954	127,350	-33.6%	Shares	Defined	2023-02-10
2022-09-30	$1,366,100	191,868	-9.7%	Shares	Defined	2022-11-14
2022-06-30	$1,718,987	212,483	+2.3%	Shares	Defined	2022-08-12
2022-03-31	$2,883,264	207,728	+205.7%	Shares	Defined	2022-05-16
2021-03-31	$2,735,868	67,955	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.